Transchem Limited (TRANSCHEM) Fair Value & Analysis
Financial Services · IN · Market cap ₹4.0B
Fair value as of: Jul 6, 2026
From 9 valuation models · updated today
Share price +14.9% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹39.19 – ₹356.15 · fair‑value band ₹52.64 – ₹87.73 · the ₹328.45 price screens above the ₹70.18 fair value. As of Jul 6, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Transchem Limited (TRANSCHEM) currently trades at ₹328.45, while our model-based Fair Value estimate is ₹70.18 — implying the stock looks roughly 78.6% overvalued today. We read business quality at 67/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Trailing-twelve-month revenue stands at ₹24.2M. It earns a return on equity of 5.3%. The stock trades on a trailing P/E of 93.6. Fundamentals as of Jul 6, 2026
Our scenario range runs from ₹52.64 (bear case) to ₹87.73 (bull case); at ₹328.45, the current price sits above that range. The share trades about 8% below its 52-week high, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -61% fair-value upside — at -79%, TRANSCHEM screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.
About the company
Transchem Limited does not have significant operations. Previously, it was engaged in the growing and processing of mushrooms. The company was incorporated in 1976 and is based in Thane, India.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Transchem Limited reported revenue of ₹0 in FY2025 versus ₹0 in FY2021. Reported net income was ₹43.0M in FY2025, compounding +10.6%/yr from FY2021.
Is TRANSCHEM fairly valued? → Check now
Similar stocks
10 more Shell Companies stocks, each showing price versus our Fair Value estimate (as of Jul 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Coca-Cola Company COLA | C$27.96 | C$10.91 | -61% |
| Lionheart III Corp LION | $13.81 | $27.62 | +100% |
| Agriculture & Natural Solutions Acquisition Corporation ANSC | $11.40 | $4.13 | -64% |
| AA Mission Acquisition Corp AAM | $0.0310 | $0.0307 | -1% |
| GP-Act III Acquisition Corp GPAT | $10.88 | $4.30 | -60% |
| Berto Acquisition Corp TACO | $10.40 | $2.73 | -74% |
| Axiom Intelligence Acquisition Corp AXIN | $10.35 | $1.86 | -82% |
| Bold Eagle Acquisition Corp BEAG | $10.64 | $4.00 | -62% |
| Lionheart Holdings CUB | $10.79 | $7.13 | -34% |
| Graf Global Corp GRAF | $10.80 | $3.63 | -66% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Transchem Limited (TRANSCHEM) undervalued?
What is the fair value of TRANSCHEM?
What is the quality score of TRANSCHEM?
What is the revenue of Transchem Limited (TRANSCHEM)?
What is the net profit margin of TRANSCHEM?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.